相关实验视频

Updated: May 7, 2026

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate

Published on: September 9, 2011

缺乏症通过调节CREM表达来加剧诱导的互白素-2抑制

Hannah E Trojan¹, Lothar Rink¹, Jana Jakobs¹

¹Institute of Immunology, Faculty of Medicine, RWTH Aachen University Hospital, Pauwelsstraße 30, 52074 Aachen, Germany.

International journal of molecular sciences

|January 11, 2025

概括

暴露于会降低T细胞中介素-2 (IL-2) 的产生,这种效应因缺乏症而恶化. 补充剂通过调节CREM 100kDa表达来保护这种由引起的免疫损伤.

科学领域:

免疫学免疫学免疫学
毒理学毒理学毒理学
细胞生物学细胞生物学

背景情况:

暴露于会损害T细胞的功能,并降低互白素-2 (IL-2) 的产生.
缺乏也会对T细胞产生负面影响,并与IL-2减少有关.
转录因子CREM 100 kDa表达量的增加与缺乏和IL-2下调有关.

研究的目的:

研究T细胞中诱导的IL-2减少的分子机制.
检查状态在调节对T细胞影响中的作用.
为了确定是否可以减轻T细胞中的毒性.

主要方法:

在不同的条件下 (充足,缺乏,补充) 暴露于的Jurkat T细胞.
测量了CREM 100kDa的表达和IL-2的产生.
分析了和状态对这些参数的影响.

主要成果:

暴露增加了CREM 100kDa表达,并降低了IL-2的产生.
缺会放大的作用,导致CREM100 kDa过度表达和IL-2水平降低.
补充剂逆转了这些影响,使CREM 100 kDa表达和IL-2水平正常化.

结论:

CREM 100 kDa被确定为T细胞中诱导的IL-2减少的分子媒介.
缺会加剧对IL-2产生的有害影响.
适当的含量对于保护T细胞功能免受毒性的作用至关重要.

关键词:

克雷姆克雷姆是什么意思在IL-2中,IL-2被认为是IL-2.在T细胞,T细胞.领导领导领导领导领导领导领导领导领导领导 ,和的使用情况.

更多相关视频

Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow

Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow

Published on: November 4, 2016

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

相关概念视频

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Inflammatory Bowel Disease III: Crohn's Disease

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...